Full Year 2019 Futura Medical PLC Earnings Call Transcript
Hello, everyone. I am James Barder, the Chief Executive of Futura Medical, and I'm pleased to welcome you to the webcast of Futura's audited results for the year ending 31st of December 2019. And also our investor seminar where Ken James, Executive Director and Head of R&D, will provide a detailed analysis of the very exciting results from our Phase III study, known as FM57. I'm also very pleased to welcome back Professor David Ralph, who has kindly agreed to provide his presentation on current treatments for erectile dysfunction on unmet needs. David's presentation will be found in part 2 of our webcast.
First of all, can I please draw your attention to the disclaimer issued on Slide 2 of this presentation? Futura is located at the research park in Guildford in Surrey. We describe ourselves as a virtual organization with 13 staff and a significant outsourced infrastructure with over 30 consultants. I think this is particularly relevant for us in recent circumstances of COVID-19. The move to working from home has been
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |